Skip to main content
Clinical Trials/NCT02331329
NCT02331329CompletedNot Applicable

Evaluation of NICOM (Bioreactance) for the Non-invasive Determination of Cardiac Output

Universitätsmedizin Mannheim0 sites41 target enrollmentStarted: July 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
41
Primary Endpoint
agreement of NICOM and MRT cardiac output measurements

Study Overview

Brief Summary

Cardiac output (CO) is an important parameter in the diagnosis and therapy of cardiac diseases. The current standard methods for the determination of CO, however, are either invasive (e.g. right heart catheterization) or technically expendable and expensive (magnetic resonance tomography, MRT). Therefore, the aim of the study at hand was to evaluate NICOM (bioreactance) as a new method for determinion of CO and to compare this new technique to MRT.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • indication for cardiac magnetic resonance imaging

Exclusion Criteria

  • pace maker
  • patient unwilling to participate

Outcomes

Primary Outcomes

agreement of NICOM and MRT cardiac output measurements

Time Frame: at time of inclusion

precision of NICOM cardiac output measurements

Time Frame: at time of inclusion

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Joachim Saur

senior physician

Universitätsmedizin Mannheim

Similar Trials